These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 17113112)

  • 21. Nefopam and ketoprofen synergy in rodent models of antinociception.
    Girard P; Verniers D; Coppé MC; Pansart Y; Gillardin JM
    Eur J Pharmacol; 2008 Apr; 584(2-3):263-71. PubMed ID: 18316069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organizational and activational effects of testosterone on carrageenan-induced inflammatory pain and morphine analgesia.
    Borzan J; Fuchs PN
    Neuroscience; 2006 Dec; 143(3):885-93. PubMed ID: 17008018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of intravenous Injections Paederiae and Stauntonia on spontaneous pain, hyperalgesia and inflammation induced by cutaneous chemical tissue injury in the rat.
    Peng XL; Gao XL; Chen J; Huang X; Chen HS
    Sheng Li Xue Bao; 2003 Oct; 55(5):516-24. PubMed ID: 14566397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophrenia.
    Robbins MJ; Starr KR; Honey A; Soffin EM; Rourke C; Jones GA; Kelly FM; Strum J; Melarange RA; Harris AJ; Rocheville M; Rupniak T; Murdock PR; Jones DN; Kew JN; Maycox PR
    Brain Res; 2007 Jun; 1152():215-27. PubMed ID: 17434465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing.
    Jones CK; Eberle EL; Peters SC; Monn JA; Shannon HE
    Neuropharmacology; 2005; 49 Suppl 1():206-18. PubMed ID: 15998527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticonvulsant and neuroprotective effect of (S)-3,4-dicarboxyphenylglycine against seizures induced in immature rats by homocysteic acid.
    Folbergrová J; Druga R; Haugvicová R; Mares P; Otáhal J
    Neuropharmacology; 2008 Mar; 54(4):665-75. PubMed ID: 18191956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats.
    Honore P; Wismer CT; Mikusa J; Zhu CZ; Zhong C; Gauvin DM; Gomtsyan A; El Kouhen R; Lee CH; Marsh K; Sullivan JP; Faltynek CR; Jarvis MF
    J Pharmacol Exp Ther; 2005 Jul; 314(1):410-21. PubMed ID: 15837818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain.
    Schiene K; De Vry J; Tzschentke TM
    J Pharmacol Exp Ther; 2011 Nov; 339(2):537-44. PubMed ID: 21816956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats.
    Yamamoto T; Saito O; Aoe T; Bartolozzi A; Sarva J; Zhou J; Kozikowski A; Wroblewska B; Bzdega T; Neale JH
    Eur J Neurosci; 2007 Jan; 25(1):147-58. PubMed ID: 17241276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pain is a salient "stressor" that is mediated by corticotropin-releasing factor-1 receptors.
    Hummel M; Cummons T; Lu P; Mark L; Harrison JE; Kennedy JD; Whiteside GT
    Neuropharmacology; 2010 Sep; 59(3):160-6. PubMed ID: 20470804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain.
    Walker KM; Urban L; Medhurst SJ; Patel S; Panesar M; Fox AJ; McIntyre P
    J Pharmacol Exp Ther; 2003 Jan; 304(1):56-62. PubMed ID: 12490575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification of formalin-induced nociception by different histamine receptor agonists and antagonists.
    Farzin D; Nosrati F
    Eur Neuropsychopharmacol; 2007 Jan; 17(2):122-8. PubMed ID: 16631358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
    Bileviciute-Ljungar I; Spetea M; Guo Y; Schütz J; Windisch P; Schmidhammer H
    J Pharmacol Exp Ther; 2006 Apr; 317(1):220-7. PubMed ID: 16339394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha.
    LoVerme J; Russo R; La Rana G; Fu J; Farthing J; Mattace-Raso G; Meli R; Hohmann A; Calignano A; Piomelli D
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1051-61. PubMed ID: 16997973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential modulation of inflammatory pain by a selective estrogen receptor beta agonist.
    Gardell LR; Hyldtoft L; Del Tredici AL; Andersen CB; Fairbairn LC; Lund BW; Gustafsson M; Brann MR; Olsson R; Piu F
    Eur J Pharmacol; 2008 Sep; 592(1-3):158-9. PubMed ID: 18644363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide].
    La Rana G; Russo R; Campolongo P; Bortolato M; Mangieri RA; Cuomo V; Iacono A; Raso GM; Meli R; Piomelli D; Calignano A
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1365-71. PubMed ID: 16510698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiallodynic effects of NMDA glycine(B) antagonists in neuropathic pain: possible peripheral mechanisms.
    Christoph T; Reissmüller E; Schiene K; Englberger W; Chizh BA
    Brain Res; 2005 Jun; 1048(1-2):218-27. PubMed ID: 15922311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat.
    Kowaluk EA; Mikusa J; Wismer CT; Zhu CZ; Schweitzer E; Lynch JJ; Lee CH; Jiang M; Bhagwat SS; Gomtsyan A; McKie J; Cox BF; Polakowski J; Reinhart G; Williams M; Jarvis MF
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1165-74. PubMed ID: 11082454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioural profile of selective ligands for mGlu7 and mGlu8 glutamate receptors in agonistic encounters between mice.
    Navarro JF; de Castro V; Martín-López M
    Psicothema; 2009 Aug; 21(3):475-9. PubMed ID: 19622332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1alphabeta gene-deficient mice show reduced nociceptive sensitivity in models of inflammatory and neuropathic pain but not post-operative pain.
    Honore P; Wade CL; Zhong C; Harris RR; Wu C; Ghayur T; Iwakura Y; Decker MW; Faltynek C; Sullivan J; Jarvis MF
    Behav Brain Res; 2006 Feb; 167(2):355-64. PubMed ID: 16256210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.